SHL TELEMEDICINE N/ IL0010855885 /
| 2024-05-08 5:31:55 PM | Chg. -0.2000 | Volume | Bid5:40:00 PM | Ask5:40:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 3.7000CHF | -5.13% | 11,703 Turnover: 44,204.1900 |
3.6000Bid Size: 1,000 | 4.4800Ask Size: 559 | 60.55 mill.CHF | - | - |
Assets
|
2019 IFRS in mill. USD |
2020 IFRS in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 3.3000 | 3.4000 | 4.0250 | 4.6520 | 4.8920 | ||||||
| Intangible Assets | 22.6000 | 22.9000 | 20.7870 | 20.4250 | 20.2570 | ||||||
| Long-Term Investments | .4000 | .4000 | .4450 | .6680 | .4750 | ||||||
| Fixed Assets | 46.2000 | 46.9000 | 83.7300 | 78.4950 | 72.9910 | ||||||
| Inventories | 1.1000 | 1.4000 | 4.2020 | 3.8790 | 3.4590 | ||||||
| Accounts Receivable | 5.7000 | 5.9000 | 8.1300 | 7.7970 | 8.5570 | ||||||
| Cash and Cash Equivalents | 6.1000 | 4.1000 | 14.8450 | 4.4830 | 6.6930 | ||||||
| Current Assets | 13.6000 | 17.9000 | 45.8620 | 32.2880 | 40.0580 | ||||||
| Total Assets | 59.8000 | 64.8000 | 129.5920 | 110.7830 | 113.0490 | ||||||
Liabilities
|
2019 IFRS in mill. USD |
2020 IFRS in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1.1000 | 1.6000 | 2.8850 | 3.7570 | 3.8840 | ||||||
| Long-term debt | - | - | 28.3620 | 22.3100 | 10.4600 | ||||||
| Liabilities to Banks | 0.0000 | 2.3000 | - | - | - | ||||||
| Provisions | .4000 | .2000 | 3.4340 | 2.7000 | 2.3130 | ||||||
| Liabilities | 25.1000 | 26.9000 | 68.8290 | 51.4940 | 36.5880 | ||||||
| Share Capital | .0310 | .0310 | - | - | .0480 | ||||||
| Total Equity | 34.7000 | 37.9000 | 56.8520 | 55.6870 | 73.5280 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 3.9110 | 3.6020 | 2.9330 | ||||||
| Total liabilities equity | 59.8000 | 64.8000 | 129.5920 | 110.7830 | 113.0490 | ||||||
Income Statement
|
2019 IFRS in mill. USD |
2020 IFRS in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 41.9000 | 40.2000 | 49.5820 | 58.9980 | 57.0750 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 5.1000 | .4000 | -.4970 | -5.1660 | -9.0060 | ||||||
| Interest Income | - | - | -12.5910 | 6.4780 | 3.0420 | ||||||
| Income Before Taxes | 4.8000 | .0800 | -13.4690 | 1.3120 | -5.9640 | ||||||
| Income Taxes | .9000 | -.3800 | .4550 | 1.0970 | .8910 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | .1860 | .2910 | .2010 | ||||||
| Net Income | 5.7000 | -.3000 | -14.1100 | -.0760 | -7.0560 | ||||||
Per Share
Cash Flow
|
2019 IFRS in mill. USD |
2020 IFRS in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 10.9000 | 4.7000 | .1850 | -.0730 | -1.4960 | ||||||
| Cash Flow from Investing Activities | 2.5000 | -7.6000 | -40.9740 | -6.4330 | -9.3460 | ||||||
| Cash Flow from Financing | -11.9000 | .7000 | 51.0780 | -2.2810 | 13.6670 | ||||||
| Decrease / Increase in Cash | 1.6000 | -1.9000 | - | - | - | ||||||
| Employees | - | - | - | - | - | ||||||
